These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18541474)

  • 1. Mass spectrometric quantification of asparagine synthetase in circulating leukemia cells from acute lymphoblastic leukemia patients.
    Abbatiello SE; Pan YX; Zhou M; Wayne AS; Veenstra TD; Hunger SP; Kilberg MS; Eyler JR; Richards NG; Conrads TP
    J Proteomics; 2008 Apr; 71(1):61-70. PubMed ID: 18541474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the asparagine synthetase level in leukemia cells by monoclonal antibodies.
    Kusano-Arai O; Iwanari H; Mochizuki Y; Nakata H; Kodama T; Kitoh T; Hamakubo T
    Hybridoma (Larchmt); 2012 Oct; 31(5):325-32. PubMed ID: 23098298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between asparaginase sensitivity and asparagine synthetase protein content, but not mRNA, in acute lymphoblastic leukemia cell lines.
    Su N; Pan YX; Zhou M; Harvey RC; Hunger SP; Kilberg MS
    Pediatr Blood Cancer; 2008 Feb; 50(2):274-9. PubMed ID: 17514734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between asparagine synthetase expression level and cell sensitivity to L-asparaginase in human leukemic cell lines].
    Li BS; He YY; Luo CY; Jiang H; Shen SH; Jiang LM; Zhang B; Gu LJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):559-63. PubMed ID: 20561401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression levels of ASNS in mesenchymal stromal cells in childhood acute lymphoblastic leukemia.
    Dimitriou H; Choulaki C; Perdikogianni C; Stiakaki E; Kalmanti M
    Int J Hematol; 2014 Mar; 99(3):305-10. PubMed ID: 24474640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low expression of asparagine synthetase in lymphoid blasts precludes its role in sensitivity to L-asparaginase.
    Hermanova I; Zaliova M; Trka J; Starkova J
    Exp Hematol; 2012 Aug; 40(8):657-65. PubMed ID: 22542578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of asparagine synthetase fails to avert cell cycle arrest induced by L-asparaginase in TEL/AML1-positive leukaemic cells.
    Krejci O; Starkova J; Otova B; Madzo J; Kalinova M; Hrusak O; Trka J
    Leukemia; 2004 Mar; 18(3):434-41. PubMed ID: 14724653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase.
    Iwamoto S; Mihara K; Downing JR; Pui CH; Campana D
    J Clin Invest; 2007 Apr; 117(4):1049-57. PubMed ID: 17380207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of
    Watanabe A; Miyake K; Yamada Y; Sunamura EI; Yotani T; Kagami K; Kasai S; Tamai M; Harama D; Akahane K; Goi K; Sakaguchi K; Goto H; Kitahara S; Inukai T
    Epigenetics; 2023 Dec; 18(1):2268814. PubMed ID: 37839090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asparagine synthetase chemotherapy.
    Richards NG; Kilberg MS
    Annu Rev Biochem; 2006; 75():629-54. PubMed ID: 16756505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumoral microenvironment prevents de novo asparagine biosynthesis in B cell lymphoma, regardless of ASNS expression.
    Grima-Reyes M; Vandenberghe A; Nemazanyy I; Meola P; Paul R; Reverso-Meinietti J; Martinez-Turtos A; Nottet N; Chan WK; Lorenzi PL; Marchetti S; Ricci JE; Chiche J
    Sci Adv; 2022 Jul; 8(27):eabn6491. PubMed ID: 35857457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of allele-specific methylation of the ASNS gene with asparaginase sensitivity and prognosis in T-ALL.
    Akahane K; Kimura S; Miyake K; Watanabe A; Kagami K; Yoshimura K; Shinohara T; Harama D; Kasai S; Goi K; Kawai T; Hata K; Kiyokawa N; Koh K; Imamura T; Horibe K; Look AT; Minegishi M; Sugita K; Takita J; Inukai T
    Blood Adv; 2022 Jan; 6(1):212-224. PubMed ID: 34535013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Asparagine Synthetase in Tumorgenicity Using Patient-Derived Tumor-Initiating Cells.
    Nishikawa G; Kawada K; Hanada K; Maekawa H; Itatani Y; Miyoshi H; Taketo MM; Obama K
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of asparagine synthetase predicts in vitro response to L-asparaginase in canine lymphoid cell lines.
    Smallwood TL; Small GW; Suter SE; Richards KL
    Leuk Lymphoma; 2014 Jun; 55(6):1357-65. PubMed ID: 24033105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reverse Phase Proteomic Array Profiling of Asparagine Synthetase Expression in Newly Diagnosed Acute Myeloid Leukemia.
    Narayanan N; Marvin-Peek J; Abouelnaaj MK; Majid D; Wang B; Brown BD; Qiu Y; Kornblau SM; Abbas HA
    J Proteome Res; 2024 Jul; 23(7):2495-2504. PubMed ID: 38829961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutaminase Activity of L-Asparaginase Contributes to Durable Preclinical Activity against Acute Lymphoblastic Leukemia.
    Chan WK; Horvath TD; Tan L; Link T; Harutyunyan KG; Pontikos MA; Anishkin A; Du D; Martin LA; Yin E; Rempe SB; Sukharev S; Konopleva M; Weinstein JN; Lorenzi PL
    Mol Cancer Ther; 2019 Sep; 18(9):1587-1592. PubMed ID: 31209181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asparagine synthetase is partially localized to the plasma membrane and upregulated by L-asparaginase in U937 cells.
    He Y; Li B; Luo C; Shen S; Chen J; Xue H; Tang J; Gu L
    J Huazhong Univ Sci Technolog Med Sci; 2011 Apr; 31(2):159-163. PubMed ID: 21505976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells.
    Lorenzi PL; Reinhold WC; Rudelius M; Gunsior M; Shankavaram U; Bussey KJ; Scherf U; Eichler GS; Martin SE; Chin K; Gray JW; Kohn EC; Horak ID; Von Hoff DD; Raffeld M; Goldsmith PK; Caplen NJ; Weinstein JN
    Mol Cancer Ther; 2006 Nov; 5(11):2613-23. PubMed ID: 17088436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The glutaminase activity of L-asparaginase is not required for anticancer activity against ASNS-negative cells.
    Chan WK; Lorenzi PL; Anishkin A; Purwaha P; Rogers DM; Sukharev S; Rempe SB; Weinstein JN
    Blood; 2014 Jun; 123(23):3596-606. PubMed ID: 24659632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of aberrant ASNS imprinting with asparaginase sensitivity and chromosomal abnormality in childhood BCP-ALL.
    Watanabe A; Miyake K; Nordlund J; Syvänen AC; van der Weyden L; Honda H; Yamasaki N; Nagamachi A; Inaba T; Ikawa T; Urayama KY; Kiyokawa N; Ohara A; Kimura S; Kubota Y; Takita J; Goto H; Sakaguchi K; Minegishi M; Iwamoto S; Shinohara T; Kagami K; Abe M; Akahane K; Goi K; Sugita K; Inukai T
    Blood; 2020 Nov; 136(20):2319-2333. PubMed ID: 32573712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.